Last 12 months
Inside the activity.
2 purchase rows · 16 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 1 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 7 |
| Jul 2026 | 1 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 9 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 19, 2023 Filed May 22, 2023 20:25 UTC |
JUNIUS DANIEL MDirector
|
GrantStock Option (right to buy) · Derivative | 35,000 | $0.00 Strike: $1.98 | $0.00 |
DisclosureSEC source: 0001209191-23-031462 · doc4.xml · derivative · entry 1 JUNIUS DANIEL M · CIK 0001094159 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2033-05-18 F1 · derivative.exercise_date: The shares underlying this option vest on May 19, 2024, subject to the reporting person's continuous service as of such vesting date. Read SEC document |
| May 19, 2023 Filed May 22, 2023 16:20 UTC |
Andrews Patricia SDirector
|
GrantStock Option (right to buy) · Derivative | 35,000 | $0.00 Strike: $1.98 | $0.00 |
DisclosureSEC source: 0001209191-23-031446 · doc4.xml · derivative · entry 1 Andrews Patricia S · CIK 0001445710 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2033-05-18 F1 · derivative.exercise_date: The shares underlying this option vest on May 19, 2024, subject to the reporting person's continuous service as of such vesting date. Read SEC document |
| May 19, 2023 Filed May 22, 2023 20:27 UTC |
King Rachel K.Director
|
GrantStock Option (right to buy) · Derivative | 35,000 | $0.00 Strike: $1.98 | $0.00 |
DisclosureSEC source: 0001209191-23-031465 · doc4.xml · derivative · entry 1 King Rachel K. · CIK 0001589712 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2033-05-18 F1 · derivative.exercise_date: The shares underlying this option vest on May 19, 2024, subject to the reporting person's continuous service as of such vesting date. Read SEC document |
| May 19, 2023 Filed May 22, 2023 20:24 UTC |
Koenig ScottDirector
|
GrantStock Option (right to buy) · Derivative | 35,000 | $0.00 Strike: $1.98 | $0.00 |
DisclosureSEC source: 0001209191-23-031456 · doc4.xml · derivative · entry 1 Koenig Scott · CIK 0001587514 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2033-05-18 F1 · derivative.exercise_date: The shares underlying this option vest on May 19, 2024, subject to the reporting person's continuous service as of such vesting date. Read SEC document |
| May 19, 2023 Filed May 22, 2023 20:23 UTC |
Goldberg Mark AlanDirector
|
GrantStock Option (right to buy) · Derivative | 35,000 | $0.00 Strike: $1.98 | $0.00 |
DisclosureSEC source: 0001209191-23-031454 · doc4.xml · derivative · entry 1 Goldberg Mark Alan · CIK 0001532475 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2033-05-18 F1 · derivative.exercise_date: The shares underlying this option vest on May 19, 2024, subject to the reporting person's continuous service as of such vesting date. Read SEC document |
| May 19, 2023 Filed May 22, 2023 20:21 UTC |
PEARSON TIMOTHY RDirector
|
GrantStock Option (right to buy) · Derivative | 35,000 | $0.00 Strike: $1.98 | $0.00 |
DisclosureSEC source: 0001209191-23-031451 · doc4.xml · derivative · entry 1 PEARSON TIMOTHY R · CIK 0001528617 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2033-05-18 F1 · derivative.exercise_date: The shares underlying this option vest on May 19, 2024, subject to the reporting person's continuous service as of such vesting date. Read SEC document |
| May 19, 2023 Filed May 22, 2023 20:18 UTC |
Jackson Scott ThomasDirector
|
GrantStock Option (right to buy) · Derivative | 35,000 | $0.00 Strike: $1.98 | $0.00 |
DisclosureSEC source: 0001209191-23-031443 · doc4.xml · derivative · entry 1 Jackson Scott Thomas · CIK 0001566617 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2033-05-18 F1 · derivative.exercise_date: The shares underlying this option vest on May 19, 2024, subject to the reporting person's continuous service as of such vesting date. Read SEC document |
| May 17, 2023 Filed May 18, 2023 20:27 UTC |
Hahn Brian M.SVP Finance, CFO
|
SaleCommon Stock | 3,700 | $1.95 | $7,215.00 |
DisclosureSEC source: 0001209191-23-030636 · doc4.xml · nonDerivative · entry 1 Hahn Brian M. · CIK 0001589711 · SVP Finance, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,143 F1 · kind: The sales reported on this Form 4 were effected to satisfy tax withholding obligations in connection with the settlement of restricted stock units as part of a "sell to cover" transaction and do not represent discretionary trades by the reporting person. Read SEC document |
| May 10, 2023 Filed May 11, 2023 21:08 UTC |
JUNIUS DANIEL MDirector
|
PurchaseCommon Stock | 30,000 | $1.56 | $46,800.00 |
DisclosureSEC source: 0001209191-23-028816 · doc4.xml · nonDerivative · entry 1 JUNIUS DANIEL M · CIK 0001094159 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,250 Read SEC document |
| May 08, 2023 Filed May 9, 2023 21:00 UTC |
Johnson Bruce SSVP & Chief Commercial Officer
|
PurchaseCommon Stock | 13,500 | $1.57 | $21,195.00 |
DisclosureSEC source: 0001209191-23-028305 · doc4.xml · nonDerivative · entry 1 Johnson Bruce S · CIK 0001971197 · SVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 138,980 Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 22:33 UTC |
Invus Public Equities, L.P.10% owner
Artal International S.C.A.10% owner
Artal International Management S.A.10% owner
Artal Group S.A.10% owner
Westend S.A.10% owner
Wittouck Amaury10% owner
Invus Public Equities Advisors, LLC10% owner
|
PurchaseCommon Stock | 100,000 | $1.70 | $170,000.00 |
DisclosureSEC source: 0000899243-23-006426 · doc4.xml · nonDerivative · entry 1 Invus Public Equities, L.P. · CIK 0001340097 · 10% owner Artal International S.C.A. · CIK 0001218180 · 10% owner Artal International Management S.A. · CIK 0001522131 · 10% owner Artal Group S.A. · CIK 0001053906 · 10% owner Westend S.A. · CIK 0001283968 · 10% owner Wittouck Amaury · CIK 0001841311 · 10% owner Stichting Administratiekantoor Westend · CIK 0001460840 · 10% owner Invus Public Equities Advisors, LLC · CIK 0001340096 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,589,064 F1 · ownership.direct: The Common Stock is held directly by Invus Public Equities, L.P. The general partner of Invus Public Equities, L.P. is Invus Public Equities Advisors, LLC. The Geneva branch of Artal International S.C.A. is the managing member of Invus Public Equities Advisors, LLC. The managing partner of Artal International S.C.A. is Artal International Management S.A., which is a wholly owned subsidiary of Artal Group S.A. Westend S.A. is the parent company of Artal Group, S.A., and the majority stockholder of Westend S.A. is Stichting Administratiekantoor Westend ("Stichting"). F2 · ownership.direct: (Continued from Footnote 1) Mr. Amaury Wittouck is the sole member of the board of Stichting. Each of the Reporting Persons, other than Invus Public Equities L.P., disclaims beneficial ownership of the securities held by the other Reporting Persons, except to the extent of such reporting person's pecuniary interest therein, and, pursuant to Rule 16a-1(a)(4) under the Exchange Act, each of the reporting persons (other than to the extent it directly holds securities reported herein) states that the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 of the Exchange Act or for any other purpose. Read SEC document |
| February 23, 2023 Filed Feb 23, 2023 23:23 UTC |
Invus Public Equities, L.P.10% owner
Artal International S.C.A.10% owner
Artal International Management S.A.10% owner
Artal Group S.A.10% owner
Westend S.A.10% owner
Wittouck Amaury10% owner
Invus Public Equities Advisors, LLC10% owner
|
PurchaseCommon Stock | 200,000 | $1.75 | $350,760.00 |
DisclosureSEC source: 0000899243-23-006027 · doc4.xml · nonDerivative · entry 3 Invus Public Equities, L.P. · CIK 0001340097 · 10% owner Artal International S.C.A. · CIK 0001218180 · 10% owner Artal International Management S.A. · CIK 0001522131 · 10% owner Artal Group S.A. · CIK 0001053906 · 10% owner Westend S.A. · CIK 0001283968 · 10% owner Wittouck Amaury · CIK 0001841311 · 10% owner Stichting Administratiekantoor Westend · CIK 0001460840 · 10% owner Invus Public Equities Advisors, LLC · CIK 0001340096 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,489,064 F4 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.72 to $1.795 per share, inclusive. The Reporting Persons undertake to provide to GlycoMimetics, Inc., any security holder of GlycoMimetics, Inc., or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F1 · ownership.direct: The Common Stock is held directly by Invus Public Equities, L.P. The general partner of Invus Public Equities, L.P. is Invus Public Equities Advisors, LLC. The Geneva branch of Artal International S.C.A. is the managing member of Invus Public Equities Advisors, LLC. The managing partner of Artal International S.C.A. is Artal International Management S.A., which is a wholly owned subsidiary of Artal Group S.A. Westend S.A. is the parent company of Artal Group, S.A., and the majority stockholder of Westend S.A. is Stichting Administratiekantoor Westend ("Stichting"). F2 · ownership.direct: (Continued from Footnote 1) Mr. Amaury Wittouck is the sole member of the board of Stichting. Each of the Reporting Persons, other than Invus Public Equities L.P., disclaims beneficial ownership of the securities held by the other Reporting Persons, except to the extent of such reporting person's pecuniary interest therein, and, pursuant to Rule 16a-1(a)(4) under the Exchange Act, each of the reporting persons (other than to the extent it directly holds securities reported herein) states that the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 of the Exchange Act or for any other purpose. Read SEC document |
| February 22, 2023 Filed Feb 23, 2023 23:23 UTC |
Invus Public Equities, L.P.10% owner
Artal International S.C.A.10% owner
Artal International Management S.A.10% owner
Artal Group S.A.10% owner
Westend S.A.10% owner
Wittouck Amaury10% owner
Invus Public Equities Advisors, LLC10% owner
|
PurchaseCommon Stock | 150,000 | $1.79 | $268,995.00 |
DisclosureSEC source: 0000899243-23-006027 · doc4.xml · nonDerivative · entry 2 Invus Public Equities, L.P. · CIK 0001340097 · 10% owner Artal International S.C.A. · CIK 0001218180 · 10% owner Artal International Management S.A. · CIK 0001522131 · 10% owner Artal Group S.A. · CIK 0001053906 · 10% owner Westend S.A. · CIK 0001283968 · 10% owner Wittouck Amaury · CIK 0001841311 · 10% owner Stichting Administratiekantoor Westend · CIK 0001460840 · 10% owner Invus Public Equities Advisors, LLC · CIK 0001340096 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,289,064 F3 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.75 to $1.82 per share, inclusive. The Reporting Persons undertake to provide to GlycoMimetics, Inc., any security holder of GlycoMimetics, Inc., or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F1 · ownership.direct: The Common Stock is held directly by Invus Public Equities, L.P. The general partner of Invus Public Equities, L.P. is Invus Public Equities Advisors, LLC. The Geneva branch of Artal International S.C.A. is the managing member of Invus Public Equities Advisors, LLC. The managing partner of Artal International S.C.A. is Artal International Management S.A., which is a wholly owned subsidiary of Artal Group S.A. Westend S.A. is the parent company of Artal Group, S.A., and the majority stockholder of Westend S.A. is Stichting Administratiekantoor Westend ("Stichting"). F2 · ownership.direct: (Continued from Footnote 1) Mr. Amaury Wittouck is the sole member of the board of Stichting. Each of the Reporting Persons, other than Invus Public Equities L.P., disclaims beneficial ownership of the securities held by the other Reporting Persons, except to the extent of such reporting person's pecuniary interest therein, and, pursuant to Rule 16a-1(a)(4) under the Exchange Act, each of the reporting persons (other than to the extent it directly holds securities reported herein) states that the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 of the Exchange Act or for any other purpose. Read SEC document |
| February 21, 2023 Filed Feb 23, 2023 23:23 UTC |
Invus Public Equities, L.P.10% owner
Artal International S.C.A.10% owner
Artal International Management S.A.10% owner
Artal Group S.A.10% owner
Westend S.A.10% owner
Wittouck Amaury10% owner
Invus Public Equities Advisors, LLC10% owner
|
PurchaseCommon Stock | 50,000 | $1.85 | $92,500.00 |
DisclosureSEC source: 0000899243-23-006027 · doc4.xml · nonDerivative · entry 1 Invus Public Equities, L.P. · CIK 0001340097 · 10% owner Artal International S.C.A. · CIK 0001218180 · 10% owner Artal International Management S.A. · CIK 0001522131 · 10% owner Artal Group S.A. · CIK 0001053906 · 10% owner Westend S.A. · CIK 0001283968 · 10% owner Wittouck Amaury · CIK 0001841311 · 10% owner Stichting Administratiekantoor Westend · CIK 0001460840 · 10% owner Invus Public Equities Advisors, LLC · CIK 0001340096 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,139,064 F1 · ownership.direct: The Common Stock is held directly by Invus Public Equities, L.P. The general partner of Invus Public Equities, L.P. is Invus Public Equities Advisors, LLC. The Geneva branch of Artal International S.C.A. is the managing member of Invus Public Equities Advisors, LLC. The managing partner of Artal International S.C.A. is Artal International Management S.A., which is a wholly owned subsidiary of Artal Group S.A. Westend S.A. is the parent company of Artal Group, S.A., and the majority stockholder of Westend S.A. is Stichting Administratiekantoor Westend ("Stichting"). F2 · ownership.direct: (Continued from Footnote 1) Mr. Amaury Wittouck is the sole member of the board of Stichting. Each of the Reporting Persons, other than Invus Public Equities L.P., disclaims beneficial ownership of the securities held by the other Reporting Persons, except to the extent of such reporting person's pecuniary interest therein, and, pursuant to Rule 16a-1(a)(4) under the Exchange Act, each of the reporting persons (other than to the extent it directly holds securities reported herein) states that the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 of the Exchange Act or for any other purpose. Read SEC document |
| February 17, 2023 Filed Feb 17, 2023 22:29 UTC |
Invus Public Equities, L.P.10% owner
Artal International S.C.A.10% owner
Artal International Management S.A.10% owner
Artal Group S.A.10% owner
Westend S.A.10% owner
Wittouck Amaury10% owner
Invus Public Equities Advisors, LLC10% owner
|
PurchaseCommon Stock | 200,000 | $1.71 | $341,000.00 |
DisclosureSEC source: 0000899243-23-005502 · doc4.xml · nonDerivative · entry 3 Invus Public Equities, L.P. · CIK 0001340097 · 10% owner Artal International S.C.A. · CIK 0001218180 · 10% owner Artal International Management S.A. · CIK 0001522131 · 10% owner Artal Group S.A. · CIK 0001053906 · 10% owner Westend S.A. · CIK 0001283968 · 10% owner Wittouck Amaury · CIK 0001841311 · 10% owner Stichting Administratiekantoor Westend · CIK 0001460840 · 10% owner Invus Public Equities Advisors, LLC · CIK 0001340096 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,089,064 F5 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.64 to $1.77 per share, inclusive. The Reporting Persons undertake to provide to GlycoMimetics, Inc., any security holder of GlycoMimetics, Inc., or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F1 · ownership.direct: The Common Stock is held directly by Invus Public Equities, L.P. The general partner of Invus Public Equities, L.P. is Invus Public Equities Advisors, LLC. The Geneva branch of Artal International S.C.A. is the managing member of Invus Public Equities Advisors, LLC. The managing partner of Artal International S.C.A. is Artal International Management S.A., which is a wholly owned subsidiary of Artal Group S.A. Westend S.A. is the parent company of Artal Group, S.A., and the majority stockholder of Westend S.A. is Stichting Administratiekantoor Westend ("Stichting"). F2 · ownership.direct: (Continued from Footnote 1) Mr. Amaury Wittouck is the sole member of the board of Stichting. Each of the Reporting Persons, other than Invus Public Equities L.P., disclaims beneficial ownership of the securities held by the other Reporting Persons, except to the extent of such reporting person's pecuniary interest therein, and, pursuant to Rule 16a-1(a)(4) under the Exchange Act, each of the reporting persons (other than to the extent it directly holds securities reported herein) states that the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 of the Exchange Act or for any other purpose. Read SEC document |
| February 16, 2023 Filed Feb 17, 2023 22:29 UTC |
Invus Public Equities, L.P.10% owner
Artal International S.C.A.10% owner
Artal International Management S.A.10% owner
Artal Group S.A.10% owner
Westend S.A.10% owner
Wittouck Amaury10% owner
Invus Public Equities Advisors, LLC10% owner
|
PurchaseCommon Stock | 315,266 | $1.68 | $531,128.63 |
DisclosureSEC source: 0000899243-23-005502 · doc4.xml · nonDerivative · entry 2 Invus Public Equities, L.P. · CIK 0001340097 · 10% owner Artal International S.C.A. · CIK 0001218180 · 10% owner Artal International Management S.A. · CIK 0001522131 · 10% owner Artal Group S.A. · CIK 0001053906 · 10% owner Westend S.A. · CIK 0001283968 · 10% owner Wittouck Amaury · CIK 0001841311 · 10% owner Stichting Administratiekantoor Westend · CIK 0001460840 · 10% owner Invus Public Equities Advisors, LLC · CIK 0001340096 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,889,064 F4 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.47 to $1.80 per share, inclusive. The Reporting Persons undertake to provide to GlycoMimetics, Inc., any security holder of GlycoMimetics, Inc., or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F1 · ownership.direct: The Common Stock is held directly by Invus Public Equities, L.P. The general partner of Invus Public Equities, L.P. is Invus Public Equities Advisors, LLC. The Geneva branch of Artal International S.C.A. is the managing member of Invus Public Equities Advisors, LLC. The managing partner of Artal International S.C.A. is Artal International Management S.A., which is a wholly owned subsidiary of Artal Group S.A. Westend S.A. is the parent company of Artal Group, S.A., and the majority stockholder of Westend S.A. is Stichting Administratiekantoor Westend ("Stichting"). F2 · ownership.direct: (Continued from Footnote 1) Mr. Amaury Wittouck is the sole member of the board of Stichting. Each of the Reporting Persons, other than Invus Public Equities L.P., disclaims beneficial ownership of the securities held by the other Reporting Persons, except to the extent of such reporting person's pecuniary interest therein, and, pursuant to Rule 16a-1(a)(4) under the Exchange Act, each of the reporting persons (other than to the extent it directly holds securities reported herein) states that the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 of the Exchange Act or for any other purpose. Read SEC document |
| February 15, 2023 Filed Feb 17, 2023 22:29 UTC |
Invus Public Equities, L.P.10% owner
Artal International S.C.A.10% owner
Artal International Management S.A.10% owner
Artal Group S.A.10% owner
Westend S.A.10% owner
Wittouck Amaury10% owner
Invus Public Equities Advisors, LLC10% owner
|
PurchaseCommon Stock | 1,000,000 | $2.16 | $2,155,800.00 |
DisclosureSEC source: 0000899243-23-005502 · doc4.xml · nonDerivative · entry 1 Invus Public Equities, L.P. · CIK 0001340097 · 10% owner Artal International S.C.A. · CIK 0001218180 · 10% owner Artal International Management S.A. · CIK 0001522131 · 10% owner Artal Group S.A. · CIK 0001053906 · 10% owner Westend S.A. · CIK 0001283968 · 10% owner Wittouck Amaury · CIK 0001841311 · 10% owner Stichting Administratiekantoor Westend · CIK 0001460840 · 10% owner Invus Public Equities Advisors, LLC · CIK 0001340096 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,573,798 F3 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.75 to $2.50 per share, inclusive. The Reporting Persons undertake to provide to GlycoMimetics, Inc., any security holder of GlycoMimetics, Inc., or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F1 · ownership.direct: The Common Stock is held directly by Invus Public Equities, L.P. The general partner of Invus Public Equities, L.P. is Invus Public Equities Advisors, LLC. The Geneva branch of Artal International S.C.A. is the managing member of Invus Public Equities Advisors, LLC. The managing partner of Artal International S.C.A. is Artal International Management S.A., which is a wholly owned subsidiary of Artal Group S.A. Westend S.A. is the parent company of Artal Group, S.A., and the majority stockholder of Westend S.A. is Stichting Administratiekantoor Westend ("Stichting"). F2 · ownership.direct: (Continued from Footnote 1) Mr. Amaury Wittouck is the sole member of the board of Stichting. Each of the Reporting Persons, other than Invus Public Equities L.P., disclaims beneficial ownership of the securities held by the other Reporting Persons, except to the extent of such reporting person's pecuniary interest therein, and, pursuant to Rule 16a-1(a)(4) under the Exchange Act, each of the reporting persons (other than to the extent it directly holds securities reported herein) states that the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 of the Exchange Act or for any other purpose. Read SEC document |
| February 09, 2023 Filed Feb 13, 2023 22:45 UTC |
Invus Public Equities, L.P.10% owner
Artal International S.C.A.10% owner
Artal International Management S.A.10% owner
Artal Group S.A.10% owner
Westend S.A.10% owner
Wittouck Amaury10% owner
Invus Public Equities Advisors, LLC10% owner
|
PurchaseCommon Stock | 11,451 | $3.24 | $37,123.00 |
DisclosureSEC source: 0000899243-23-004819 · doc4.xml · nonDerivative · entry 1 Invus Public Equities, L.P. · CIK 0001340097 · 10% owner Artal International S.C.A. · CIK 0001218180 · 10% owner Artal International Management S.A. · CIK 0001522131 · 10% owner Artal Group S.A. · CIK 0001053906 · 10% owner Westend S.A. · CIK 0001283968 · 10% owner Wittouck Amaury · CIK 0001841311 · 10% owner Stichting Administratiekantoor Westend · CIK 0001460840 · 10% owner Invus Public Equities Advisors, LLC · CIK 0001340096 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,573,798 F3 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.07 to $3.30 per share, inclusive. The Reporting Persons undertake to provide to GlycoMimetics, Inc., any security holder of GlycoMimetics, Inc., or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F1 · ownership.direct: The Common Stock is held directly by Invus Public Equities, L.P. The general partner of Invus Public Equities, L.P. is Invus Public Equities Advisors, LLC. The Geneva branch of Artal International S.C.A. is the managing member of Invus Public Equities Advisors, LLC. The managing partner of Artal International S.C.A. is Artal International Management S.A., which is a wholly owned subsidiary of Artal Group S.A. Westend S.A. is the parent company of Artal Group, S.A., and the majority stockholder of Westend S.A. is Stichting Administratiekantoor Westend ("Stichting"). F2 · ownership.direct: (Continued from Footnote 1) Mr. Amaury Wittouck is the sole member of the board of Stichting. Each of the Reporting Persons, other than Invus Public Equities L.P., disclaims beneficial ownership of the securities held by the other Reporting Persons, except to the extent of such reporting person's pecuniary interest therein, and, pursuant to Rule 16a-1(a)(4) under the Exchange Act, each of the reporting persons (other than to the extent it directly holds securities reported herein) states that the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 of the Exchange Act or for any other purpose. Read SEC document |
| January 27, 2023 Filed Jan 30, 2023 21:13 UTC |
Koenig ScottDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 10,500 | $0.00 Strike: $2.55 | $0.00 |
DisclosureSEC source: 0001209191-23-005471 · doc4.xml · derivative · entry 2 Koenig Scott · CIK 0001587514 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,500 shares Expires 2031-05-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The shares underlying this option vested on May 18, 2022 and are fully exercisable. Read SEC document |
| January 27, 2023 Filed Jan 30, 2023 21:13 UTC |
Koenig ScottDirector
|
Exercise / conversionCommon Stock | 10,500 | $2.55 | $26,775.00 |
DisclosureSEC source: 0001209191-23-005471 · doc4.xml · nonDerivative · entry 1 Koenig Scott · CIK 0001587514 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 26, 2023 Filed Jan 27, 2023 22:15 UTC |
SANDELL SCOTT D10% owner
|
SaleCommon Stock | 1,351,092 | $3.12 | $4,213,785.73 |
DisclosureSEC source: 0001209191-23-005326 · doc4.xml · nonDerivative · entry 4 SANDELL SCOTT D · CIK 0001237289 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Note 3 Disclosed balance after: 2,237,196 F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.00 to $3.26 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The Reporting Person is a director of NEA 13 GP, LTD, which is the sole general partner of NEA Partners 13, L.P. ("NEA Partners 13"). NEA Partners 13 is the sole general partner of New Enterprise Associates 13, L.P. ("NEA 13"), which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securitites Exchange Act of 1934, as amended, or otherwise of such portion of the NEA 13 shares in which the Reporting Person has no pecuniary interest. Read SEC document |
| January 26, 2023 Filed Jan 27, 2023 22:15 UTC |
SANDELL SCOTT D10% owner
|
SaleCommon Stock | 1,648,908 | $3.12 | $5,142,614.27 |
DisclosureSEC source: 0001209191-23-005326 · doc4.xml · nonDerivative · entry 3 SANDELL SCOTT D · CIK 0001237289 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Note 2 Disclosed balance after: 2,730,334 F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.00 to $3.26 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: The Reporting Person is a general partner of NEA Partners 10, Limited Partnership ("NEA Partners 10"). NEA Partners 10 is the sole general partner of New Enterprise Associates 10, Limited Partnership ("NEA 10"), the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the NEA 10 shares in which the Reporting Person has no pecuniary interest. Read SEC document |
| January 25, 2023 Filed Jan 27, 2023 22:15 UTC |
SANDELL SCOTT D10% owner
|
SaleCommon Stock | 293,645 | $3.26 | $958,427.92 |
DisclosureSEC source: 0001209191-23-005326 · doc4.xml · nonDerivative · entry 2 SANDELL SCOTT D · CIK 0001237289 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Note 3 Disclosed balance after: 3,588,288 F1 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.05 to $3.46 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The Reporting Person is a director of NEA 13 GP, LTD, which is the sole general partner of NEA Partners 13, L.P. ("NEA Partners 13"). NEA Partners 13 is the sole general partner of New Enterprise Associates 13, L.P. ("NEA 13"), which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securitites Exchange Act of 1934, as amended, or otherwise of such portion of the NEA 13 shares in which the Reporting Person has no pecuniary interest. Read SEC document |
| January 25, 2023 Filed Jan 27, 2023 22:15 UTC |
SANDELL SCOTT D10% owner
|
SaleCommon Stock | 358,371 | $3.26 | $1,169,687.11 |
DisclosureSEC source: 0001209191-23-005326 · doc4.xml · nonDerivative · entry 1 SANDELL SCOTT D · CIK 0001237289 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Note 2 Disclosed balance after: 4,379,242 F1 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.05 to $3.46 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: The Reporting Person is a general partner of NEA Partners 10, Limited Partnership ("NEA Partners 10"). NEA Partners 10 is the sole general partner of New Enterprise Associates 10, Limited Partnership ("NEA 10"), the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the NEA 10 shares in which the Reporting Person has no pecuniary interest. Read SEC document |
| January 19, 2023 Filed Jan 20, 2023 16:04 UTC |
Semerjian HaroutDirector · Chief Executive Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 651,200 | $0.00 Strike: $2.55 | $0.00 |
DisclosureSEC source: 0001209191-23-004218 · doc4.xml · derivative · entry 1 Semerjian Harout · CIK 0001809747 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 651,200 Underlying: Common Stock · 651,200 shares Expires 2033-01-18 F1 · derivative.exercise_date: 25% of the shares underlying this option will vest on January 19, 2024 and the remaining shares will vest in equal monthly installments over 36 months thereafter, subject to the Reporting Person's continued service with the Issuer through each such vesting date. Read SEC document |
| January 19, 2023 Filed Jan 20, 2023 21:08 UTC |
Hahn Brian M.SVP Finance, CFO
|
GrantEmployee Stock Option (right to buy) · Derivative | 246,300 | $0.00 Strike: $2.55 | $0.00 |
DisclosureSEC source: 0001209191-23-004228 · doc4.xml · derivative · entry 1 Hahn Brian M. · CIK 0001589711 · SVP Finance, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,300 Underlying: Common Stock · 246,300 shares Expires 2033-01-18 F1 · derivative.exercise_date: 25% of the shares underlying this option will vest on January 19, 2024 and the remaining shares will vest in equal monthly installments over 36 months thereafter, subject to the Reporting Person's continued service with the Issuer through each such vesting date. Read SEC document |
| January 19, 2023 Filed Jan 20, 2023 21:02 UTC |
Rock EdwinChief Medical Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 244,800 | $0.00 Strike: $2.55 | $0.00 |
DisclosureSEC source: 0001209191-23-004212 · doc4.xml · derivative · entry 1 Rock Edwin · CIK 0001945417 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 244,800 Underlying: Common Stock · 244,800 shares Expires 2033-01-18 F1 · derivative.exercise_date: 25% of the shares underlying this option will vest on January 19, 2024 and the remaining shares will vest in equal monthly installments over 36 months thereafter, subject to the Reporting Person's continued service with the Issuer through each such vesting date. Read SEC document |
| January 05, 2023 Filed Jan 6, 2023 23:35 UTC |
SANDELL SCOTT D10% owner
|
SaleCommon Stock | 32,139 | $2.76 | $88,658.65 |
DisclosureSEC source: 0001209191-23-002468 · doc4.xml · nonDerivative · entry 2 SANDELL SCOTT D · CIK 0001237289 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Note 3 Disclosed balance after: 3,881,933 F1 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.50 to $2.90 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The Reporting Person is a director of NEA 13 GP, LTD, which is the sole general partner of NEA Partners 13, L.P. ("NEA Partners 13"). NEA Partners 13 is the sole general partner of New Enterprise Associates 13, L.P. ("NEA 13"), which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securitites Exchange Act of 1934, as amended, or otherwise of such portion of the NEA 13 shares in which the Reporting Person has no pecuniary interest. Read SEC document |
| January 05, 2023 Filed Jan 6, 2023 23:35 UTC |
SANDELL SCOTT D10% owner
|
SaleCommon Stock | 39,223 | $2.76 | $108,200.57 |
DisclosureSEC source: 0001209191-23-002468 · doc4.xml · nonDerivative · entry 1 SANDELL SCOTT D · CIK 0001237289 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Note 2 Disclosed balance after: 4,737,613 F1 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.50 to $2.90 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: The Reporting Person is a general partner of NEA Partners 10, Limited Partnership ("NEA Partners 10"). NEA Partners 10 is the sole general partner of New Enterprise Associates 10, Limited Partnership ("NEA 10"), the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the NEA 10 shares in which the Reporting Person has no pecuniary interest. Read SEC document |
| January 04, 2023 Filed Jan 4, 2023 22:26 UTC |
SANDELL SCOTT D10% owner
|
SaleCommon Stock | 45,930 | $2.91 | $133,642.52 |
DisclosureSEC source: 0001209191-23-001186 · doc4.xml · nonDerivative · entry 6 SANDELL SCOTT D · CIK 0001237289 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Note 3 Disclosed balance after: 3,914,072 F5 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.85 to $2.96 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The Reporting Person is a director of NEA 13 GP, LTD, which is the sole general partner of NEA Partners 13, L.P. ("NEA Partners 13"). NEA Partners 13 is the sole general partner of New Enterprise Associates 13, L.P. ("NEA 13"), which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securitites Exchange Act of 1934, as amended, or otherwise of such portion of the NEA 13 shares in which the Reporting Person has no pecuniary interest. Read SEC document |
| January 04, 2023 Filed Jan 4, 2023 22:26 UTC |
SANDELL SCOTT D10% owner
|
SaleCommon Stock | 56,054 | $2.91 | $163,100.32 |
DisclosureSEC source: 0001209191-23-001186 · doc4.xml · nonDerivative · entry 5 SANDELL SCOTT D · CIK 0001237289 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Note 2 Disclosed balance after: 4,776,836 F5 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.85 to $2.96 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: The Reporting Person is a general partner of NEA Partners 10, Limited Partnership ("NEA Partners 10"). NEA Partners 10 is the sole general partner of New Enterprise Associates 10, Limited Partnership ("NEA 10"), the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the NEA 10 shares in which the Reporting Person has no pecuniary interest. Read SEC document |
| January 03, 2023 Filed Jan 4, 2023 22:26 UTC |
SANDELL SCOTT D10% owner
|
SaleCommon Stock | 78,730 | $2.99 | $235,410.57 |
DisclosureSEC source: 0001209191-23-001186 · doc4.xml · nonDerivative · entry 4 SANDELL SCOTT D · CIK 0001237289 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Note 3 Disclosed balance after: 3,960,002 F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.86 to $3.225 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The Reporting Person is a director of NEA 13 GP, LTD, which is the sole general partner of NEA Partners 13, L.P. ("NEA Partners 13"). NEA Partners 13 is the sole general partner of New Enterprise Associates 13, L.P. ("NEA 13"), which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securitites Exchange Act of 1934, as amended, or otherwise of such portion of the NEA 13 shares in which the Reporting Person has no pecuniary interest. Read SEC document |
| January 03, 2023 Filed Jan 4, 2023 22:26 UTC |
SANDELL SCOTT D10% owner
|
SaleCommon Stock | 96,084 | $2.99 | $287,300.77 |
DisclosureSEC source: 0001209191-23-001186 · doc4.xml · nonDerivative · entry 3 SANDELL SCOTT D · CIK 0001237289 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Note 2 Disclosed balance after: 4,832,890 F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.86 to $3.225 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: The Reporting Person is a general partner of NEA Partners 10, Limited Partnership ("NEA Partners 10"). NEA Partners 10 is the sole general partner of New Enterprise Associates 10, Limited Partnership ("NEA 10"), the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the NEA 10 shares in which the Reporting Person has no pecuniary interest. Read SEC document |
| December 30, 2022 Filed Jan 4, 2023 22:26 UTC |
SANDELL SCOTT D10% owner
|
SaleCommon Stock | 54,645 | $3.02 | $165,027.90 |
DisclosureSEC source: 0001209191-23-001186 · doc4.xml · nonDerivative · entry 2 SANDELL SCOTT D · CIK 0001237289 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Note 3 Disclosed balance after: 4,038,732 F1 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.93 to $3.09 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The Reporting Person is a director of NEA 13 GP, LTD, which is the sole general partner of NEA Partners 13, L.P. ("NEA Partners 13"). NEA Partners 13 is the sole general partner of New Enterprise Associates 13, L.P. ("NEA 13"), which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securitites Exchange Act of 1934, as amended, or otherwise of such portion of the NEA 13 shares in which the Reporting Person has no pecuniary interest. Read SEC document |
| December 30, 2022 Filed Jan 4, 2023 22:26 UTC |
SANDELL SCOTT D10% owner
|
SaleCommon Stock | 66,690 | $3.02 | $201,403.80 |
DisclosureSEC source: 0001209191-23-001186 · doc4.xml · nonDerivative · entry 1 SANDELL SCOTT D · CIK 0001237289 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Note 2 Disclosed balance after: 4,928,974 F1 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.93 to $3.09 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: The Reporting Person is a general partner of NEA Partners 10, Limited Partnership ("NEA Partners 10"). NEA Partners 10 is the sole general partner of New Enterprise Associates 10, Limited Partnership ("NEA 10"), the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the NEA 10 shares in which the Reporting Person has no pecuniary interest. Read SEC document |
| December 22, 2022 Filed Dec 27, 2022 23:41 UTC |
Rock EdwinChief Medical Officer
|
PurchaseCommon Stock | 110,000 | $2.25 | $247,500.00 |
DisclosureSEC source: 0001209191-22-062741 · doc4.xml · nonDerivative · entry 1 Rock Edwin · CIK 0001945417 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 310,000 F1 · price: The Reporting Person purchased the securities on the open market at purchase prices ranging from $2.20 to $2.25 per share, with a weighted average purchase price of $2.25 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| November 17, 2022 Filed Nov 18, 2022 21:01 UTC |
JUNIUS DANIEL MDirector
|
PurchaseCommon Stock | 20,000 | $1.87 | $37,400.00 |
DisclosureSEC source: 0001209191-22-057823 · doc4.xml · nonDerivative · entry 1 JUNIUS DANIEL M · CIK 0001094159 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,250 F1 · price: The Reporting Person purchased the securities on the open market at purchase prices ranging from $1.855 to $1.89 per share, with a weighted average purchase price of $1.87 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| November 15, 2022 Filed Nov 16, 2022 21:26 UTC |
Rock EdwinChief Medical Officer
|
PurchaseCommon Stock | 100,000 | $1.66 | $166,000.00 |
DisclosureSEC source: 0001209191-22-057314 · doc4.xml · nonDerivative · entry 2 Rock Edwin · CIK 0001945417 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 F2 · price: The Reporting Person purchased the securities on the open market at purchase prices ranging from $1.52 to $1.75 per share, with a weighted average purchase price of $1.66 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| November 14, 2022 Filed Nov 16, 2022 21:26 UTC |
Rock EdwinChief Medical Officer
|
PurchaseCommon Stock | 100,000 | $1.43 | $143,000.00 |
DisclosureSEC source: 0001209191-22-057314 · doc4.xml · nonDerivative · entry 1 Rock Edwin · CIK 0001945417 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 F1 · price: The Reporting Person purchased the securities on the open market at purchase prices ranging from $1.31 to $1.55 per share, with a weighted average purchase price of $1.43 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| November 11, 2022 Filed Nov 14, 2022 16:13 UTC |
Semerjian HaroutDirector · Chief Executive Officer
|
PurchaseCommon Stock | 25,000 | $1.29 | $32,250.00 |
DisclosureSEC source: 0001209191-22-056581 · doc4.xml · nonDerivative · entry 1 Semerjian Harout · CIK 0001809747 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 F1 · price: The Reporting Person purchased the securities on the open market at purchase prices ranging from $1.27 to $1.29 per share, with a weighted average purchase price of $1.29 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| November 11, 2022 Filed Nov 14, 2022 21:14 UTC |
PEARSON TIMOTHY RDirector
|
PurchaseCommon Stock | 19,400 | $1.29 | $25,026.00 |
DisclosureSEC source: 0001209191-22-056587 · doc4.xml · nonDerivative · entry 1 PEARSON TIMOTHY R · CIK 0001528617 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,650 Read SEC document |
| November 11, 2022 Filed Nov 14, 2022 21:13 UTC |
Hahn Brian M.SVP Finance, CFO
|
PurchaseCommon Stock | 20,000 | $1.06 | $21,200.00 |
DisclosureSEC source: 0001209191-22-056576 · doc4.xml · nonDerivative · entry 1 Hahn Brian M. · CIK 0001589711 · SVP Finance, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,843 F1 · price: The Reporting Person purchased the securities on the open market at purchase prices ranging from $1.03 to $1.15 per share, with a weighted average purchase price of $1.06 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| November 11, 2022 Filed Nov 14, 2022 21:11 UTC |
Magnani John L.SVP of Research, CSO
|
PurchaseCommon Stock | 45,045 | $1.17 | $52,702.65 |
DisclosureSEC source: 0001209191-22-056573 · doc4.xml · nonDerivative · entry 1 Magnani John L. · CIK 0001589713 · SVP of Research, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 366,078 F1 · price: The Reporting Person purchased the securities on the open market at purchase prices ranging from $1.10 to $1.20 per share, with a weighted average purchase price of $1.17 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| November 11, 2022 Filed Nov 14, 2022 21:04 UTC |
Girard ArmandSVP, Chief Business Officer
|
PurchaseCommon Stock | 6,500 | $1.05 | $6,825.00 |
DisclosureSEC source: 0001209191-22-056563 · doc4.xml · nonDerivative · entry 1 Girard Armand · CIK 0001769636 · SVP, Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,161 Read SEC document |
| September 02, 2022 Filed Sep 7, 2022 20:10 UTC |
Rock EdwinChief Medical Officer
|
GrantEmployee stock option (right to buy) · Derivative | 200,000 | $0.00 Strike: $0.74 | $0.00 |
DisclosureSEC source: 0001209191-22-048996 · doc4.xml · derivative · entry 1 Rock Edwin · CIK 0001945417 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2032-09-01 F1 · derivative.exercise_date: 25% of the shares underlying this option will vest on September 2, 2023 and the remaining underlying shares will vest in equal monthly installments over 36 months thereafter, subject to the Reporting Person's continued service with the Issuer through each such vesting date. Read SEC document |
| August 02, 2022 Filed Feb 6, 2023 21:13 UTC |
King Rachel K.Director
|
OtherCommon Stock | 7,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-007267 · doc5.xml · nonDerivative · entry 2 King Rachel K. · CIK 0001589712 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By RBK LLC Disclosed balance after: 7,500 F3 · ownership.nature: The reporting person is co-manager of this entity. She disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein. Read SEC document |
| May 18, 2022 Filed May 20, 2022 20:13 UTC |
JUNIUS DANIEL MDirector
|
GrantStock Option (right to buy) · Derivative | 21,000 | $0.00 Strike: $0.60 | $0.00 |
DisclosureSEC source: 0001209191-22-030991 · doc4.xml · derivative · entry 1 JUNIUS DANIEL M · CIK 0001094159 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,000 Underlying: Common Stock · 21,000 shares Expires 2032-05-17 F1 · derivative.exercise_date: The shares underlying this option vest on May 18, 2023, subject to the reporting person's continuous service as of such vesting date. Read SEC document |
| May 18, 2022 Filed May 20, 2022 16:06 UTC |
Andrews Patricia SDirector
|
GrantStock Option (right to buy) · Derivative | 21,000 | $0.00 Strike: $0.60 | $0.00 |
DisclosureSEC source: 0001209191-22-030966 · doc4.xml · derivative · entry 1 Andrews Patricia S · CIK 0001445710 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,000 Underlying: Common Stock · 21,000 shares Expires 2032-05-17 F1 · derivative.exercise_date: The shares underlying this option vest on May 18, 2023, subject to the reporting person's continuous service as of such vesting date. Read SEC document |
| May 18, 2022 Filed May 20, 2022 20:19 UTC |
Koenig ScottDirector
|
GrantStock Option (right to buy) · Derivative | 21,000 | $0.00 Strike: $0.60 | $0.00 |
DisclosureSEC source: 0001209191-22-031007 · doc4.xml · derivative · entry 1 Koenig Scott · CIK 0001587514 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,000 Underlying: Common Stock · 21,000 shares Expires 2032-05-17 F1 · derivative.exercise_date: The shares underlying this option vest on May 18, 2023, subject to the reporting person's continuous service as of such vesting date. Read SEC document |
| May 18, 2022 Filed May 20, 2022 20:20 UTC |
PEARSON TIMOTHY RDirector
|
GrantStock Option (right to buy) · Derivative | 21,000 | $0.00 Strike: $0.60 | $0.00 |
DisclosureSEC source: 0001209191-22-031010 · doc4.xml · derivative · entry 1 PEARSON TIMOTHY R · CIK 0001528617 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,000 Underlying: Common Stock · 21,000 shares Expires 2032-05-17 F1 · derivative.exercise_date: The shares underlying this option vest on May 18, 2023, subject to the reporting person's continuous service as of such vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.